Company Profiles

driven by the PitchBook Platform

Euclises Pharmaceuticals

Description

Operator of a drug discovery and development company. The company is focused on advancing novel cyclooxygenase-2 (COX-2) inhibitors for cancer therapy. The company is developing a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform.

2011

Founded

PRIVATE

Status

Series A

Latest Deal Type

$2.78M

Total Amount Raised

7

Investors

Description

Operator of a drug discovery and development company. The company is focused on advancing novel cyclooxygenase-2 (COX-2) inhibitors for cancer therapy. The company is developing a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform.

Website:

www.euclises.com

Formerly Known As

Talley NewCo

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery
Biotechnology

Primary Office

BioGenerator Accelerator Labs 4320 Forest Park Avenue Suite 304 St. Louis, MO 63108United States +1 (314) 690-1441
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Euclises Pharmaceuticals's full profile, request a free trial.

    Euclises Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Euclises Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Euclises Pharmaceuticals Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    ABC LaboratoriesCorporationMinority000 0000000 0000
    BioGeneratorNot-For-Profit Venture CapitalMinority000 0000000 0000
    Cultivation CapitalVenture CapitalMinority000 0000000 0000
    Helix Center Biotech IncubatorAccelerator/IncubatorMinority000 0000000 0000
    iSelect FundVenture CapitalMinority000 0000000 0000
    ABC Laboratories Corporation
    BioGenerator Not-For-Profit Venture Capital
    Cultivation Capital Venture Capital
    Helix Center Biotech Incubator Accelerator/Incubator
    iSelect Fund Venture Capital

    Euclises Pharmaceuticals Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Bobby Sandage Ph.DChief Executive Officer, Board Member & President
    Rajesh Devraj Ph.DChief Executive Officer, President and Board Member
    Robert Karr MDExecutive Director & Co-Founder
    Eduardo MartinezCo-Founder
    Kathleen BeckmannChief Financial Officer
    Bobby Sandage Ph.D Chief Executive Officer, Board Member & President
    Rajesh Devraj Ph.D Chief Executive Officer, President and Board Member
    Robert Karr MD Executive Director & Co-Founder
    Eduardo Martinez Co-Founder
    Kathleen Beckmann Chief Financial Officer

    Euclises Pharmaceuticals Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Bobby Sandage Ph.DEuclises PharmaceuticalsChief Executive Officer, Board Member & President000 0000
    Charles BoltenBioGeneratorBoard Member000 0000
    Rajesh Devraj Ph.DEuclises PharmaceuticalsChief Executive Officer, President and Board Member000 0000
    Rick Ryan Ph.DCultivation CapitalBoard Member000 0000
    Robert Beardsley Ph.DSelfBoard Member & Business Advisor000 0000
    Bobby Sandage Ph.D Chief Executive Officer, Board Member & President Euclises Pharmaceuticals
    Charles Bolten Board Member BioGenerator
    Rajesh Devraj Ph.D Chief Executive Officer, President and Board Member Euclises Pharmaceuticals
    Rick Ryan Ph.D Board Member Cultivation Capital
    Robert Beardsley Ph.D Board Member & Business Advisor Self
    Request full access to PitchBook